NFKB1 and diffuse large B-cell lymphoma: Constant NF-κB activation in MZ B-cells models results in abnormal B-cell expansion [90], and enhanced signaling is observed in other lymphoid malignancies including Hodgkin lymphomas, DLBCL, and multiple myeloma [91].